InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
0.941
-0.029 (-3.00%)
Mar 9, 2026, 3:00 PM EDT - Market open
InflaRx Market Cap
InflaRx has a market cap or net worth of $63.74 million as of March 9, 2026. Its market cap has decreased by -41.47% in one year.
Market Cap
63.74M
Enterprise Value
12.82M
1-Year Change
-41.47%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $63.74M, a decrease of -81.83%. That is a compound annual growth rate of -18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 65.70M | -3.95% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 66.48M |
| Impact BioMedical | 63.82M |
| OS Therapies | 63.03M |
| ImageneBio | 62.63M |
| Mereo BioPharma Group | 61.93M |
| Edesa Biotech | 61.53M |
| eXoZymes | 61.49M |
| Entera Bio | 61.22M |